A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
A phase II single arm study of carboplatin and docetaxel in treatment of first sensitive
relapse of epithelial ovarian, peritoneal or tubal cancer.
Hypothesis: Treatment with this combination in second line is safe and with a low frequency
of neurologic side effect.
Phase:
Phase 2
Details
Lead Sponsor:
Nordic Society for Gynaecologic Oncology Nordic Society of Gynaecological Oncology - Clinical Trials Unit